AI news
NVIDIA and Isomorphic Labs have officially launched AlphaFold--X, a next--generation biological foundation model capable of simulating real--time protein--ligand interactions. Moving beyond static structural predictions, AlphaFold--X incorporates dynamic molecular physics, allowing researchers to observe how drug candidates bind to moving proteins under varying cellular conditions. This "Digital Twin of the Cell" approach is projected to reduce the lead--optimization phase of drug discovery by 85%. The platform is being integrated into NVIDIA's BioNeMo cloud service, providing pharmaceutical companies with immediate access to generative chemistry tools powered by Blackwell B200 infrastructure. Expert commentary suggests this marks the transition of AI in healthcare from a diagnostic aid to a primary discovery engine.
Source: https://nvidianews.nvidia.com/news/isomorphic--labs--nvidia--alphafold--x--launch